# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 137: Amendment to Schedule 8

Extent: E+W+S+N.I.

In Schedule 8 (material to accompany an application for a UK marketing authorisation)—
(a) in paragraph 18—
(i) omit sub-paragraph (a);
(ii) in sub-paragraph (b), omit “in the case of a medicinal product for sale or supply in Great Britain,”;
(b) in paragraph 23—
(i) in sub-paragraph (a), for “medicinal product for sale or supply in Northern Ireland” substitute “UKMA(NI) or a UKMA(UK)(Category 2)”;
(ii) in sub-paragraph (b), for “medicinal product for sale or supply in Great Britain” substitute “UKMA(GB) or a UKMA(UK)(Category 1)”;
(c) in paragraph 25A, omit “for sale or supply in Great Britain”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/137 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-137
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.